Oncology

  1. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  2. Rubraca (rucaparib)
    Rubraca (rucaparib)
    by Clovis Oncology, Inc.
    for Gynaecological Cancer
    €4,970.00
  3. Zejula (niraparib)
    Zejula (niraparib)
    by Tesaro UK Limited
    for Gynaecological Cancer
    €7,647.20
View as Grid List

3 Items

per page
Set Descending Direction